New treatment options for piriformis syndrome

Kurushina O.V.; Barulin A.E.

doi:https://doi.org/10.17116/jnevro2021121091116

Kurushina O.V.

Volgograd State Medical University

SPIN RSCI: 4571-5646
Scopus AuthorID: 37008504700
ORCID: 0000-0003-4364-0123

Barulin A.E.

Volgograd State Medical University

SPIN RSCI: 6234-6783
Scopus AuthorID: 55657672800
ORCID: 0000-0001-7264-3580

New treatment options for piriformis syndrome

Authors:

Kurushina O.V., Barulin A.E.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(9): 116‑120

DOI: 10.17116/jnevro2021121091116

Read: 14075 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kurushina OV, Barulin AE. New treatment options for piriformis syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(9):116‑120. (In Russ.)
https://doi.org/10.17116/jnevro2021121091116

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Prevalence of chronic pain in adult population of the Russian Federation: an all-Russian epidemiological study. Russian Journal of Pain. 2025;(2):54-62

Biofeedback in complex therapy of pain syndromes. Russian Journal of Pain. 2025;(2):70-75

Experimental modeling and treatment of endometriosis using bovhyaluronidase azoximer in an animal model. Russian Journal of Human Reproduction. 2025;(4):26-40

New analgesics in oncology. Tafalgin employed as an alternative to opioid analgesics. P.A. Herzen Journal of Oncology. 2025;(5):73-77

Current possibilities of physiotherapy rehabilitation programs in the treatment of postoperative pain after surgical treatment of complex anal fistulas. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):28-34

The King’s Parkinson’s Disease Pain Scale: development and linguistic adaptation of the Russian version. Russian Journal of Pain. 2026;(1):47-52

Abstract:

This paper discusses modern approaches to the diagnosis and management of patients with piriformis syndrome. Epidemiological data on the prevalence of this syndrome in neurological practice are presented. The anatomical features of this region, leading to the formation of piriformis syndrome, are described in detail. The authors provide diagnostic criteria based on neurological examination and manual muscle testing and discuss the differential diagnosis of piriformis syndrome. New possibilities of treating this syndrome using a fixed combination of diclofenac and orphenadrine registered in the Russian Federation as a drug for intravenous infusion neodolpasse are discussed in detail. The authors cite materials from their own work, a clinical case of managing a patient with piriformis syndrome using neodolpasse is analyzed.

Keywords:

piriformis syndrome

pain

neodolpasse

piriformis syndrome

pain

neodolpasse

Authors:

Kurushina O.V.

Volgograd State Medical University

SPIN RSCI: 4571-5646
Scopus AuthorID: 37008504700
ORCID: 0000-0003-4364-0123

Barulin A.E.

Volgograd State Medical University

SPIN RSCI: 6234-6783
Scopus AuthorID: 55657672800
ORCID: 0000-0001-7264-3580

Received:

15.07.2021

Accepted:

15.07.2021

Close metadata

References:

Levesque A, Riant T, Ploteau S, Rigaud J, Labat JJ., Convergences PP Network. Clinical Criteria of Central Sensitization in Chronic Pelvic and Perineal Pain (Convergences PP Criteria): Elaboration of a Clinical Evaluation Tool Based on Formal Expert Consensus. Pain Med. 2018;19(10):2009-2015.
Meucci RD, Fassa AG, Faria NM. Prevalence of chronic low back pain: systematic review. Rev Saude Publica. 2015;49:1. https://doi.org/10.1590/S0034-8910.2015049005874
Barulin AE, Kurushina OV, Dumtsev VV. Modern approaches to the treatment of chronic pelvic pain. RMZH. 2016;24:13:847-851. (In Russ.).
Wu A, March L, Zheng X, Huang J, Wang X, Zhao J, Blyth F, Smith E, Buchbinder R, Hoy D. Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017. Ann Transl Med. 2020;8(6):299. https://doi.org/10.21037/atm.2020.02.175
Carregaro RL, Tottoli CR, Rodrigues DDS, Bosmans JE, da Silva EN, van Tulder M. Low back pain should be considered a health and research priority in Brazil: Lost productivity and healthcare costs between 2012 to 2016. PLoS One. 2020;15(4):e0230902. https://doi.org/10.1371/journal.pone.0230902
Fatoye F, Gebrye T, Odeyemi I. Real-world incidence and prevalence of low back pain using routinely collected data. Rheumatol Int. 2019;39:619-626. https://doi.org/10.1007/s00296-019-04273-0
Kim LH, Vail D, Azad TD, Bentley JP, Zhang Y, Ho AL, Fatemi P, Feng A, Varshneya K, Desai M, Veeravagu A, Ratliff JK. Expenditures and Health Care Utilization Among Adults With Newly Diagnosed Low Back and Lower Extremity Pain. JAMA Netw Open. 2019;2(5):e193676. https://doi.org/10.1001/jamanetworkopen.2019.3676
Siddiq MAB. Piriformis Syndrome and Wallet Neuritis: Are They the Same? Cureus. 2018;10(5):e2606.
Cassidy L, Walters A, Bubb K, Shoja MM, Tubbs RS, Loukas M. Piriformis syndrome: implications of anatomical variations, diagnostic techniques, and treatment options. Surg Radiol Anat. 2012;34(6):479-486.
Smoll NR. Variations of the piriformis and sciatic nerve with clinical consequence: a review. Clin Anat. 2010;23(1):8-17.
Huang ZF, Yang DS, Shi ZJ, Xiao J. [Pathogenesis of piriformis syndrome: a magnetic resonance imaging-based comparison study]. Zhonghua Yi Xue Za Zhi. 2018;98(1):42-45.
Hicks L, Lam C, Varacallo M. Piriformis Syndrome. 2021 Apr 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. PMID: 28846222.
Hopayian K, Danielyan A. Four symptoms define the piriformis syndrome: an updated systematic review of its clinical features. Eur J Orthop Surg Traumatol. 2018;28(2):155-164.
Vassalou EE, Katonis P, Karantanas AH. Piriformis muscle syndrome: A cross-sectional imaging study in 116 patients and evaluation of therapeutic outcome. Eur Radiol. 2018;28(2):447-458.
Barulin AE, Kurushina OV, Puchkov AE. Complex treatment of acute non-specific pain in the lower back. Nevrologiya, neyropsikhiatriya, psikhosomatika. 2014;3:38-42. (In Russ.).
Ro TH, Edmonds L. Diagnosis and Management of Piriformis Syndrome: A Rare Anatomic Variant Analyzed by Magnetic Resonance Imaging. J Clin Imaging Sci. 2018;8:6.
Safarpour Y, Jabbari B. Botulinum toxin treatment of pain syndromes - an evidence based review. Toxicon. 2018;147:120-128.
Nazlıkul H, Ural FG, Öztürk GT, Öztürk ADT. Evaluation of neural therapy effect in patients with piriformis syndrome. J Back Musculoskelet Rehabil. 2018;31(6):1105-1110.
Kay J, de Sa D, Morrison L, Fejtek E, Simunovic N, Martin HD, Ayeni OR. Surgical Management of Deep Gluteal Syndrome Causing Sciatic Nerve Entrapment: A Systematic Review. Arthroscopy. 2017;33(12):2263-2278.e1.
Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116(1):4-15. https://doi.org/10.1172/JCI27291
Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715-1731. https://doi.org/10.1185/03007995.2010.486301
Hinz B, Chevts J, Renner B, Wuttke H, Rau T, Schmidt A, Szelenyi I, Brune K, Werner U. Bioavailability of diclofenac potassium at low doses. Br J Clin Pharmacol. 2005;59(1):80-84. https://doi.org/10.1111/j.1365-2125.2005.02226.x
Davies NM, Anderson KE: Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet. 1997;33(3):184-213. https://doi.org/10.2165/00003088-199733030-00003
Pubill D, Canudas AM, Pallàs M, Sureda FX, Escubedo E, Camins A, Camarasa J. Assessment of the adrenergic effects of orphenadrine in rat vas deferens. J Pharm Pharmacol. 1999;51(3):307-312. https://doi.org/10.1211/0022357991772303
Lee SY, Oh HJ, Kim JW, Kim YG, Moon CJ, Lee EH. Pharmacokinetic study of orphenadrine using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci. 2006;839(1-2):118-123. https://doi.org/10.1016/j.jchromb.2006.02.056
Desaphy JF, Dipalma A, De Bellis M, Costanza T, Gaudioso C, Delmas P, George AL Jr, Camerino DC. Involvement of voltage-gated sodium channels blockade in the analgesic effects of orphenadrine. Pain. 2009;142(3):225-235. https://doi.org/10.1016/j.pain.2009.01.010
Schaffler K, Reitmeir P, Gschanes A, Eggenreich U. Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skin. Drugs R D. 2005;6(4):189-199. https://doi.org/10.2165/00126839-200506040-00001
Borsodi M, Nagy E, Darvas K. Diclofenac/orphenadrin kombinált analgetikum a posztoperatív fájdalomcsillapításban [Diclofenac/orphenadrine as a combined analgetic in post-operative relief of pain]. Orv Hetil. 2008;149(39):1847-1852. Hungarian. https://doi.org/10.1556/OH.2008.28419
Gombotz H, Lochner R, Sigl R, Blasl J, Herzer G, Trimmel H. Opiate sparing effect of fixed combination of diclophenac and orphenadrine after unilateral total hip arthroplasty: A double-blind, randomized, placebo-controlled, multi-centre clinical trial. Wien Med Wochenschr. 2010;160(19-20):526-534. https://doi.org/10.1007/s10354-010-0829-7
Uitz E, Aglas F, Wurm A, Rainer F. Diclofenac/Orphenadrin-Infusionstherapie bei Patienten mit aktivierten Arthrosen [Diclofenac/orphenadrine infusion therapy in patients with active arthrosis]. Wien Med Wochenschr. 1998;148(7):179-182.
Michel F, Decavel P, Toussirot E, Tatu L, Aleton E, Monnier G, Garbui P, Parratte B. The piriformis muscle syndrome: An exploration of anatomical context, pathophysiological hypotheses and diagnostic criteria. Annals of Physical and Rehabilitation Medicine. 2013;56:4:300-311.